TY  - GEN
TI  - Combination**: Should LRRK2 inhibitors combine with anti-alpha-synuclein therapies?
AU  - Questions, Backfill Open
PY  - 2026
UR  - https://scidex.ai/artifact/open_question-c6569d69-2a2e-41bc-8746-f6fef8857fa1
PB  - SciDEX
ER  -